BIO-FLURAZEPAM
BIOMED PHARMA
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is BIO-FLURAZEPAM discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that BIO-FLURAZEPAM has been permanently discontinued (last updated November 1, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SOMNOL 15MG
AXXESS PHARMA INC.
PMS-FLURAZEPAM CAP 30MG
PHARMASCIENCE INC
NOVO-FLUPAM CAP 15MG
NOVOPHARM LIMITED
SOMNOL 30MG
AXXESS PHARMA INC.
FLURAZEPAM
AA PHARMA INC
DALMANE
VALEANT CANADA LP / VALEANT CANADA S.E.C.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02248126
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from BIOMED PHARMA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
25MG · DIN 02247167
50MG · DIN 02247168
10MG · DIN 02247166
5MG · DIN 02392135
2.5MG · DIN 02392127
10MG · DIN 02392143
1MG · DIN 02392488
5MG · DIN 02527987
2.5MG · DIN 02527979
100MG · DIN 02392186
50MG · DIN 02392178
25MG · DIN 02392194